Shiferman Gregory L. bought SAGE
January 16, 2025 · Form 4 insider transaction
Shiferman Gregory L. bought 14,000 shares of SAGE Therapeutics Holdings at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,000
Price
$0.00
Total value
N/A
InsiderShiferman Gregory L.
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2025
Filing dateJanuary 21, 2025
Shares owned after33,888
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of shares of common stock issuable under 14,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on January 16, 2026.